Home / News / World News / Article / Pfizer, BioNTech not sure about vaccines' effectiveness on new Covid variant 'Omicron'

Pfizer, BioNTech not sure about vaccines' effectiveness on new Covid variant 'Omicron'

This came after the World Health Organization (WHO) announced it identified a new COVID-19 strain, the B.1.1.529 that was initially found in southern Africa. WHO named the variant with the Greek letter 'Omicron'.

Listen to this article :
Image for representational purpose only. Pic/AFP

Image for representational purpose only. Pic/AFP

The pharmaceutical companies Pfizer and BioNTech on Saturday issued a statement stating that they are not sure whether their vaccines would be able to help in the treatment of the new Covid-19 variant 'Omicron'.

The companies also promised to develop a new vaccine against the variant in about 100 days, Sputnik reported.

How do you like the new new mid-day.com experience? Share your feedback and help us improve.

Read Next Story
'Be vigilant', WHO tells Southeast Asia countries amid case surge, emergence of new variant

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement